10-QPeriod: Q2 FY2004

PROCTER & GAMBLE Co Quarterly Report for Q2 Ended Dec 31, 2003

Filed February 3, 2004For Securities:PG

Summary

Procter & Gamble reported a strong financial performance for the quarter and six months ended December 31, 2003. The company saw significant increases in net sales and net earnings, driven by robust volume growth across all business segments and geographic regions. A key factor contributing to this growth was the acquisition of Wella AG in September 2003, which significantly boosted the Beauty Care segment's performance and was accretive to earnings. The company also benefited from the completion of its restructuring program and lower manufacturing costs, though these were partially offset by increased marketing investments. Overall, P&G demonstrated impressive top-line growth and enhanced profitability, with diluted earnings per share showing a substantial increase year-over-year. The company's financial position remains solid, supported by strong cash flow from operations, although investing activities were heavily impacted by the Wella acquisition. Investors can take comfort in the company's ability to integrate major acquisitions successfully and deliver consistent growth across its diverse portfolio.

Key Highlights

  • 1Net sales for the quarter increased by 20% to $13.2 billion, and by 17% to $25.4 billion for the six-month period, driven by a 19% unit volume increase in the quarter and 16% for the six months.
  • 2Net earnings rose by 22% to $1.8 billion for the quarter and by 21% to $3.6 billion for the six months, with diluted earnings per share (EPS) increasing by 23% and 22% respectively.
  • 3The acquisition of Wella AG in September 2003 significantly contributed to the Beauty Care segment, driving its volume up by 45% (10% excluding acquisitions) and net sales by 50% for the quarter.
  • 4Gross margin expanded significantly, up 210 basis points for the quarter and 240 basis points for the six months, due to volume benefits, Wella's higher gross margin, and cost savings.
  • 5Operating income grew by 22% in the quarter and 22% in the six-month period, reflecting strong sales growth and improved gross margins, partially offset by increased marketing, research, administrative, and other expenses.
  • 6Cash flow from operations remained strong at $4.0 billion for the six months, though it decreased compared to the prior year due to increased working capital and dividends received in the prior period.
  • 7Investing activities saw a significant cash outflow of $6.1 billion for the six months, primarily due to the $5.1 billion acquisition of Wella and additional smaller acquisitions.

Frequently Asked Questions

The primary drivers were strong unit volume growth across all business segments, boosted significantly by the acquisition of Wella AG in September 2003, which particularly impacted the Beauty Care segment. Additionally, the completion of the company's restructuring program and lower manufacturing costs contributed to earnings growth.

The acquisition of Wella AG had a substantial positive impact, especially on the Beauty Care segment, driving its volume growth to 45% (10% organically) and net sales by 50% for the quarter. The acquisition was also accretive to earnings and contributed to gross margin expansion due to Wella's higher margin profile. However, it also led to increased Marketing, Research, Administrative, and Other (MRA&O) expenses due to higher marketing ratios and initial post-acquisition costs.

Despite the significant cash outflow for the Wella acquisition, the company generated strong cash flow from operations ($3.96 billion for the six months). Management anticipates being able to support short-term liquidity through operational cash flow, backed by strong credit ratings which allow for favorable debt refinancing in the commercial paper and bond markets. The company also has access to credit facilities from financial institutions.

The company elected to account for stock options using the intrinsic value method (APB Opinion No. 25), resulting in no compensation cost for options granted at or above market price. However, the filing provides pro forma disclosures showing that if stock-based compensation were accounted for using the fair value method (SFAS No. 123), net earnings and EPS would have been lower. For the six months ended December 31, 2003, pro forma net earnings would have been $3.43 billion and diluted EPS $2.44, compared to the reported $3.58 billion and $2.56 respectively.